Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1000031	注射用重组人血清白蛋白/干扰素α2a融合蛋白		Lyophilized	Biological Products(1)	New Drug Application	2010-11-01	天津林达生物科技有限公司	Tianjin Linda Biotechnology Co Ltd	Certificate Issued	2012-08-14	view
CXSB1900012	注射用重组人血清白蛋白/干扰素α2a融合蛋白		Lyophilized	Biological Products	Supplementary Application	2019-06-12	天津林达生物科技有限公司	Tianjin Linda Biotechnology Co Ltd	Certificate Issued	2020-07-29	view